Viridian Therapeutics, Inc.
VRDN • NASDAQ
Viridian Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Stephen F. Mahoney, with a market cap of $1.5B.
Market Cap$1.5B
Employees94.0
CEOStephen F. Mahoney
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Viridian Therapeutics, Inc. FAQ
Common questions about Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026 before market open. Analysts estimate revenue of $27.8K.
Viridian Therapeutics, Inc. has approximately 94 employees.